Skip to main content
ResearchTreatments

New Clinical Trial: Olaparib (LYNPARZA) Plus Durvalumab (IMFINZI) in EGFR-Mutated Adenocarcinomas That Transform..

By January 6, 2021February 26th, 2021No Comments